{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:41:12Z","timestamp":1790185272934,"version":"4.1.0"},"reference-count":76,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Genomics Medicine, Mexico"},{"name":"Hospital General de M\u00e9xico"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Acute lymphoblastic leukemia (ALL) represents around 25% of adult acute leukemias. Despite the increasing improvement in the survival rate of ALL patients during the last decade, the heterogeneous clinical and molecular features of this malignancy still represent a major challenge for treatment and achieving better outcomes. To identify aberrantly expressed genes in bone marrow (BM) samples from adults with ALL, transcriptomic analysis was performed using Affymetrix Human Transcriptome Array 2.0 (HTA 2.0). Differentially expressed genes (DEGs) (\u00b12-fold change, p-value &lt; 0.05, and FDR &lt; 0.05) were detected using the Transcriptome Analysis Console. Gene Ontology (GO), Database for Annotation, Visualization, and Integrated Discovery (DAVID), and Ingenuity Pathway Analysis (IPA) were employed to identify gene function and define the enriched pathways of DEGs. The protein\u2013protein interactions (PPIs) of DEGs were constructed. A total of 871 genes were differentially expressed, and DNTT, MYB, EBF1, SOX4, and ERG were the top five up-regulated genes. Meanwhile, the top five down-regulated genes were PTGS2, PPBP, ADGRE3, LUCAT1, and VCAN. An association between ERG, CDK6, and SOX4 expression levels and the probability of relapse and death was observed. Regulation of the immune system, immune response, cellular response to stimulus, as well as apoptosis signaling, inflammation mediated by chemokines and cytokines, and T cell activation were among the most altered biological processes and pathways, respectively. Transcriptome analysis of ALL in adults reveals a group of genes consistently associated with hematological malignancies and underscores their relevance in the development of ALL in adults.<\/jats:p>","DOI":"10.3390\/ijms25031750","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T08:44:08Z","timestamp":1706777048000},"page":"1750","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Transcriptome Analysis in Mexican Adults with Acute Lymphoblastic Leukemia"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6295-6698","authenticated-orcid":false,"given":"Gabriela Marisol","family":"Cruz-Miranda","sequence":"first","affiliation":[{"name":"Programa de Doctorado, Posgrado en Ciencias Biol\u00f3gicas, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Mexico City 04510, Mexico"},{"name":"Laboratorio de Innovaci\u00f3n en Medicina de Precisi\u00f3n N\u00facleo A, Instituto Nacional de Medicina Gen\u00f3mica, Mexico City 14610, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5374-0534","authenticated-orcid":false,"given":"Irma","family":"Olarte-Carrillo","sequence":"additional","affiliation":[{"name":"Laboratorio de Biolog\u00eda Molecular, Servicio de Hematolog\u00eda, Hospital General de M\u00e9xico Dr. Eduardo Liceaga, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Alberto","family":"B\u00e1rcenas-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Programa de Doctorado, Posgrado en Ciencias Biol\u00f3gicas, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Mexico City 04510, Mexico"},{"name":"Laboratorio de Innovaci\u00f3n en Medicina de Precisi\u00f3n N\u00facleo A, Instituto Nacional de Medicina Gen\u00f3mica, Mexico City 14610, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5713-3731","authenticated-orcid":false,"given":"Adolfo","family":"Mart\u00ednez-Tovar","sequence":"additional","affiliation":[{"name":"Laboratorio de Biolog\u00eda Molecular, Servicio de Hematolog\u00eda, Hospital General de M\u00e9xico Dr. Eduardo Liceaga, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Ram\u00edrez-Bello","sequence":"additional","affiliation":[{"name":"Subdirecci\u00f3n de Investigaci\u00f3n Cl\u00ednica, Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez, Mexico City 14080, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Omar","family":"Ramos-Pe\u00f1afiel","sequence":"additional","affiliation":[{"name":"Departamento de Hematolog\u00eda, Hospital General de M\u00e9xico Dr. Eduardo Liceaga, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anel Irais","family":"Garc\u00eda-Laguna","sequence":"additional","affiliation":[{"name":"Laboratorio de Biolog\u00eda Molecular, Servicio de Hematolog\u00eda, Hospital General de M\u00e9xico Dr. Eduardo Liceaga, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0935-4107","authenticated-orcid":false,"given":"Rafael","family":"Cer\u00f3n-Maldonado","sequence":"additional","affiliation":[{"name":"Programa de Doctorado, Posgrado en Ciencias Biol\u00f3gicas, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Mexico City 04510, Mexico"},{"name":"Laboratorio de Biolog\u00eda Molecular, Servicio de Hematolog\u00eda, Hospital General de M\u00e9xico Dr. Eduardo Liceaga, Mexico City 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7671-7310","authenticated-orcid":false,"given":"Didier","family":"May-Hau","sequence":"additional","affiliation":[{"name":"Laboratorio de Innovaci\u00f3n en Medicina de Precisi\u00f3n N\u00facleo A, Instituto Nacional de Medicina Gen\u00f3mica, Mexico City 14610, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6590-9712","authenticated-orcid":false,"given":"Silvia","family":"Jim\u00e9nez-Morales","sequence":"additional","affiliation":[{"name":"Laboratorio de Innovaci\u00f3n en Medicina de Precisi\u00f3n N\u00facleo A, Instituto Nacional de Medicina Gen\u00f3mica, Mexico City 14610, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/cncr.24862","article-title":"Adult acute lymphoblastic leukemia: Concepts and strategies","volume":"116","author":"Faderl","year":"2010","journal-title":"Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000447076","article-title":"Leukemia","volume":"43","author":"Juliusson","year":"2016","journal-title":"Prog. Tumor Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3322\/canjclin.44.6.326","article-title":"Acute leukemia in adults: Recent developments in diagnosis and treatment","volume":"44","author":"Devine","year":"1994","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.3390\/ijms20122929","article-title":"Next-Generation Sequencing in Acute Lymphoblastic Leukemia","volume":"20","author":"Coccaro","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/10428194.2017.1354372","article-title":"Advances in adult acute lymphoblastic leukemia therapy","volume":"59","author":"Aldoss","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/asheducation-2017.1.28","article-title":"Progress in adult ALL: Incorporation of new agents to frontline treatment","volume":"2017","author":"Leonard","year":"2017","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"IJH42","DOI":"10.2217\/ijh-2022-0005","article-title":"Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia","volume":"12","author":"Hanbali","year":"2023","journal-title":"Int. J. Hematol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1182\/bloodadvances.2022007197","article-title":"Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia","volume":"6","author":"Muffly","year":"2022","journal-title":"Blood Adv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13046-016-0333-z","article-title":"High expression of ID family and IGJ genes signature as predictor of low induction treatment response and worst survival in adult Hispanic patients with B-acute lymphoblastic leukemia","volume":"35","author":"Combita","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clml.2016.09.003","article-title":"Acute Leukemia Characteristics are Different around the World: The Mexican Perspective","volume":"17","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clml.2016.08.013","article-title":"Survival Rates of Adults with Acute Lymphoblastic Leukemia in a Low-Income Population: A Decade of Experience at a Single Institution in Mexico","volume":"17","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/cam4.1513","article-title":"Survival analysis of adult patients with ALL in Mexico City: First report from the Acute Leukemia Workgroup (ALWG) (GTLA)","volume":"7","year":"2018","journal-title":"Cancer Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.blre.2018.08.002","article-title":"The emerging story of acute lymphoblastic leukemia among the Latin American population-biological and clinical implications","volume":"33","author":"Quiroz","year":"2019","journal-title":"Blood Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2010-05-283309","article-title":"The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor","volume":"116","author":"Hudecek","year":"2010","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1158\/1078-0432.CCR-20-3863","article-title":"CRISPR\/Cas9-Engineered Universal CD19\/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed\/Refractory B-cell Acute Lymphoblastic Leukemia","volume":"27","author":"Hu","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/s41591-021-01436-0","article-title":"CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: A phase 1 trial","volume":"27","author":"Spiegel","year":"2021","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/cncr.29383","article-title":"New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia","volume":"121","author":"Jabbour","year":"2015","journal-title":"Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/ijc.31999","article-title":"Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia","volume":"144","author":"Papakonstantinou","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.18632\/oncotarget.27805","article-title":"RNA sequencing analyses reveal differentially expressed genes and pathways as Notch2 targets in B-cell lymphoma","volume":"11","author":"Arasu","year":"2020","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/bloodadvances.2021004962","article-title":"Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression","volume":"6","author":"Stratmann","year":"2022","journal-title":"Blood Adv."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.arcmed.2016.12.005","article-title":"Gene Expression Profiling of Acute Lymphoblastic Leukemia in Children with Very Early Relapse","volume":"47","year":"2016","journal-title":"Arch. Med. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ajh.24419","article-title":"Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-M\u00fcnster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen","volume":"91","author":"Rytting","year":"2016","journal-title":"Am. J. Hematol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bonab, S.F., and Mirakhori, M. (2020). Differential expression of apoptosis related genes in the peripheral blood mononuclear cells of acute lymphoblastic\/lymphocytic leukemia (ALL) patients. Biomed. Res. Clin. Rev.","DOI":"10.31579\/2692-9406\/008"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bcmd.2007.12.001","article-title":"Distribution of CYP1A1*2A polymorphism in adult patients with acute lymphoblastic leukemia in a Mexican population","volume":"41","author":"Figuera","year":"2008","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4067\/S0034-98872011000900004","article-title":"Results of treatment of acute lymphoblastic leukemia in two cohorts of Mexican patients","volume":"139","author":"Ramos","year":"2011","journal-title":"Rev. Med. Chil."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1182\/bloodadvances.2023009754","article-title":"A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central America","volume":"7","year":"2023","journal-title":"Blood Adv."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2016-07-726588","article-title":"Ph-like acute lymphoblastic leukemia: A high-risk subtype in adults","volume":"129","author":"Jain","year":"2017","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11912-017-0589-2","article-title":"Philadelphia-Like Acute Lymphoblastic Leukemia in Adults","volume":"19","author":"Herold","year":"2017","journal-title":"Curr. Oncol. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41525-022-00340-x","article-title":"Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma","volume":"8","author":"Pilcher","year":"2023","journal-title":"NPJ Genom. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/ng.3691","article-title":"Deregulation of DUX4 and ERG in acute lymphoblastic leukemia","volume":"48","author":"Zhang","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2174\/1573396318666220901165247","article-title":"Targeted Treatment and Immunotherapy in High-risk and Relapsed\/Refractory Pediatric Acute Lymphoblastic Leukemia","volume":"19","author":"Behluli","year":"2023","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5045\/br.2015.50.4.227","article-title":"Immunophenotypic markers in adult acute lymphoblastic leukemia: The prognostic significance of CD20 and TdT expression","volume":"50","author":"Kim","year":"2015","journal-title":"Blood Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"106462","DOI":"10.1016\/j.leukres.2020.106462","article-title":"Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia","volume":"99","author":"Ottone","year":"2020","journal-title":"Leuk. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.2019004583","article-title":"Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?","volume":"136","author":"Kramer","year":"2020","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/mc.23514","article-title":"DNTT activation, TdT-aided gene length mutation, and better prognosis in ATG-based regimen allo-HSCT in AML","volume":"62","author":"Zhou","year":"2023","journal-title":"Mol. Carcinog."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2012-05-428938","article-title":"SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia","volume":"121","author":"Geng","year":"2013","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1158\/1541-7786.MCR-15-0006-T","article-title":"LncRNA Expression Discriminates Karyotype and Predicts Survival in B-Lymphoblastic Leukemia","volume":"13","author":"Fernando","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gcc.23151","article-title":"Increased MYB alternative promoter usage is associated with relapse in acute lymphoblastic leukemia","volume":"62","author":"Fehr","year":"2023","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/gcc.22943","article-title":"MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia","volume":"60","author":"Bardelli","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/ajco.13406","article-title":"v-myb avian myeloblastosis viral oncogene homolog expression is a potential molecular diagnostic marker for B-cell acute lymphoblastic leukemia","volume":"17","year":"2021","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1158\/0008-5472.CAN-17-2644","article-title":"Targeting CDK6 and BCL2 Exploits the \u201cMYB Addiction\u201d of Ph","volume":"78","author":"Porazzi","year":"2018","journal-title":"Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.21037\/tcr-22-1377","article-title":"Expression of NMU, PPBP and GNG4 in colon cancer and their influences on prognosis","volume":"11","author":"Chen","year":"2022","journal-title":"Transl. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/07357907.2020.1808898","article-title":"Evaluation of Cytotoxic Potentials of Novel Cyclooxygenase-2 Inhibitor against ALL Lymphocytes and Normal Lymphocytes and Its Anticancer Effect through Mitochondrial Pathway","volume":"38","author":"Salimi","year":"2020","journal-title":"Cancer Investig."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Peng, L., Zhou, Y., Wang, Y., Mou, H., and Zhao, Q. (2013). Prognostic significance of COX-2 immunohistochemical expression in colorectal cancer: A meta-analysis of the literature. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058891"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1002\/jcp.27411","article-title":"Cyclooxygenase-2 in cancer: A review","volume":"234","author":"Najafi","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/ijc.22786","article-title":"Cyclooxygenase-1, but not -2, in blast cells of patients with acute leukemia","volume":"121","author":"Truffinet","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.4155\/fmc-2018-0032","article-title":"Targeting the mitochondrial apoptosis pathway by a newly synthesized COX-2 inhibitor in pediatric ALL lymphocytes","volume":"10","author":"Aghvami","year":"2018","journal-title":"Future Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e20183","DOI":"10.1097\/MD.0000000000020183","article-title":"Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases","volume":"99","author":"Yu","year":"2020","journal-title":"Medicine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1038\/s41598-023-36159-4","article-title":"Quantifiable peptide library bridges the gap for proteomics based biomarker discovery and validation on breast cancer","volume":"13","author":"Kim","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"15215","DOI":"10.1002\/jcp.28163","article-title":"Identification of differentially expressed genes and biological characteristics of colorectal cancer by integrated bioinformatics analysis","volume":"234","author":"Sun","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"16445","DOI":"10.18632\/aging.203166","article-title":"Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia","volume":"13","author":"Wang","year":"2021","journal-title":"Aging"},{"key":"ref_52","first-page":"247","article-title":"Identification of plasma RGS18 and PPBP mRNAs as potential biomarkers for gastric cancer using transcriptome arrays","volume":"17","author":"Su","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.21037\/tcr-20-2712","article-title":"Identification of six hub genes and analysis of their correlation with drug sensitivity in acute myeloid leukemia through bioinformatics","volume":"10","author":"Cai","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1002\/bab.2287","article-title":"Identification of intrinsically disordered regions in hub genes of acute myeloid leukemia: A bioinformatics approach","volume":"69","author":"Ameri","year":"2022","journal-title":"Biotechnol. Appl. Biochem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1479-5876-9-38","article-title":"Elevated expression of CDK4 in lung cancer","volume":"9","author":"Wu","year":"2011","journal-title":"J. Transl. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3324\/haematol.2022.281456","article-title":"Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against","volume":"108","author":"Niswander","year":"2023","journal-title":"Haematologica"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fped.2017.00248","article-title":"Targeting FLT3 Signaling in Childhood Acute Myeloid Leukemia","volume":"5","author":"Sexauer","year":"2017","journal-title":"Front. Pediatr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13045-018-0603-7","article-title":"Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells","volume":"11","author":"Wang","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Lo Nigro, L.L., Andriano, N., Buldini, B., Silvestri, D., Villa, T., Locatelli, F., Parasole, R., Barisone, E., Testi, A.M., and Biondi, A. (2022). FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD). Cancers, 14.","DOI":"10.3390\/cancers14102475"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1182\/blood-2010-12-317990","article-title":"ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer","volume":"117","author":"Thoms","year":"2011","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Bock, J., Mochmann, L.H., Schlee, C., Farhadi-Sartangi, N., G\u00f6llner, S., M\u00fcller-Tidow, C., and Baldus, C.D. (2013). ERG transcriptional networks in primary acute leukemia cells implicate a role for ERG in deregulated kinase signaling. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0052872"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/leu.2015.311","article-title":"Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells","volume":"30","author":"Pinz","year":"2016","journal-title":"Leukemia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12015-019-09876-5","article-title":"Targeting T Cell Malignancies Using CD4CAR T-Cells and Implementing a Natural Safety Switch","volume":"15","author":"Ma","year":"2019","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"997482","DOI":"10.3389\/fimmu.2022.997482","article-title":"Treatment of aggressive T-cell lymphoma\/leukemia with anti-CD4 CAR T cells","volume":"13","author":"Feng","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"900699","DOI":"10.3389\/fphar.2022.900699","article-title":"Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"13013","DOI":"10.18632\/oncotarget.7344","article-title":"Prognostic relevance of HER2\/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumab","volume":"7","author":"Haen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_67","first-page":"1399","article-title":"Overexpression of Her2\/neu is observed in one third of adult acute lymphoblastic leukemia patients and is associated with chemoresistance in these patients","volume":"89","author":"Chevallier","year":"2004","journal-title":"Haematologica"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2217\/imt.09.70","article-title":"Toll-like receptor agonists in cancer therapy","volume":"1","author":"Adams","year":"2009","journal-title":"Immunotherapy"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1021\/acs.molpharmaceut.8b00691","article-title":"TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings","volume":"15","author":"Boushehri","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/bioinformatics\/btn284","article-title":"FIRMA: A method for detection of alternative splicing from exon array data","volume":"24","author":"Purdom","year":"2008","journal-title":"Bioinformatics"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Korthauer, K., Kimes, P.K., Duvallet, C., Reyes, A., Subramanian, A., Teng, M., Shukla, C., Alm, E.J., and Hicks, S.C. (2019). A practical guide to methods controlling false discoveries in computational biology. Genome Biol., 20.","DOI":"10.1186\/s13059-019-1716-1"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Dennis, G., Sherman, B.T., A Hosack, D., Yang, J., Gao, W., Lane, H.C., and A Lempicki, R. (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol., 4.","DOI":"10.1186\/gb-2003-4-5-p3"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: Protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","article-title":"Cytoscape 2.8: New features for data integration and network visualization","volume":"27","author":"Smoot","year":"2011","journal-title":"Bioinformatics"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"B\u00e1rcenas-L\u00f3pez, D.A., N\u00fa\u00f1ez-Enr\u00edquez, J.C., Hidalgo-Miranda, A., Beltr\u00e1n-Anaya, F.O., May-Hau, D.I., Jim\u00e9nez-Hern\u00e1ndez, E., Bekker-M\u00e9ndez, V.C., Flores-Lujano, J., Medina-Sans\u00f3n, A., and Tamez-G\u00f3mez, E.L. (2020). Transcriptome Analysis Identifies LINC00152 as a Biomarker of Early Relapse and Mortality in Acute Lymphoblastic Leukemia. Genes, 11.","DOI":"10.3390\/genes11030302"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Ye, J., Coulouris, G., Zaretskaya, I., Cutcutache, I., Rozen, S., and Madden, T.L. (2012). Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinform., 13.","DOI":"10.1186\/1471-2105-13-134"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/3\/1750\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:52:54Z","timestamp":1760104374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/3\/1750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":76,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["ijms25031750"],"URL":"https:\/\/doi.org\/10.3390\/ijms25031750","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}